Tyrosine Phosphorylation in Lung Cancer and Its Prognostic Implications
Author Information
Author(s): M Nishimura, K Machida, M Imaizumi, T Abel, T Umeda, E Takeshima, T Watanabe, Y Ohnishi, K Takagi, M Hamaguchi
Primary Institution: Nagoya University School of Medicine
Hypothesis
Does tyrosine phosphorylation of 100-130 kDa proteins correlate with poor prognosis in lung cancer?
Conclusion
Tyrosine phosphorylation of 100-130 kDa proteins is associated with shorter survival in lung cancer patients.
Supporting Evidence
- Approximately half of the lung cancer cases showed tyrosine phosphorylation of 100-130 kDa proteins.
- Tyrosine phosphorylation was found in 47% of squamous cell carcinoma and 43% of adenocarcinoma tissues.
- Cases with nodal involvement had a higher incidence of tyrosine phosphorylation compared to those without.
Takeaway
In lung cancer, certain proteins are like flags that show how aggressive the cancer is, and if they are present, patients might not live as long.
Methodology
The study analyzed tyrosine phosphorylated proteins in lung cancer cell lines and surgical specimens using immunoprecipitation and immunoblotting.
Limitations
The study had a limited follow-up time for some patients, which may affect the survival analysis.
Participant Demographics
The study included 44 patients, 33 male and 11 female, aged 49 to 78 years (average 65 years).
Statistical Information
P-Value
0.01
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website